Cerevel Therapeutics Hldg Inc
(CERE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 11-2014 | 08-2014 | 05-2014 | 02-2014 | 11-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,973 | -29,321 | -23,157 | -15,430 | -8,205 |
| Depreciation Amortization | 189 | 1,517 | 1,191 | 809 | 414 |
| Accounts receivable | 47 | 589 | 501 | 196 | 57 |
| Other Working Capital | -1,111 | 1,348 | 617 | 1,233 | 1,125 |
| Other Operating Activity | 555 | 3,304 | 2,959 | 1,790 | 933 |
| Operating Cash Flow | $-6,293 | $-22,563 | $-17,889 | $-11,402 | $-5,676 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 7,230 | -3,385 | -5,313 | 8,541 | 4,392 |
| PPE Investments | -126 | -204 | -510 | -532 | -352 |
| Investing Cash Flow | $7,104 | $-3,589 | $-5,823 | $8,009 | $4,040 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -23 | -159 | -123 | -87 | -46 |
| Common Stock Issued | N/A | 20,751 | 20,751 | N/A | N/A |
| Financing Cash Flow | $-23 | $20,592 | $20,628 | $-87 | $-46 |
| Exchange Rate Effect | 43 | 102 | 93 | 47 | 115 |
| Beginning Cash Position | 3,423 | 8,881 | 8,881 | 8,881 | 8,881 |
| End Cash Position | 4,254 | 3,423 | 5,890 | 5,448 | 7,314 |
| Net Cash Flow | $831 | $-5,458 | $-2,991 | $-3,433 | $-1,567 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,293 | -22,563 | -17,889 | -11,402 | -5,676 |
| Capital Expenditure | -149 | -1,014 | -628 | -596 | -406 |
| Free Cash Flow | -6,442 | -23,577 | -18,517 | -11,998 | -6,082 |